NICE backs drugs for lymphoma and lung cancer from Roche and...

NICE has recommended NHS funding for a duo of cancer drugs, giving final guidance on new options for certain patients with follicular lymphoma and lung cancer. 

Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Pfizer and its development partner BioNTech have begun dosing the first people in the US with a potential COVID-19 vaccine, as part of their ongoing phase 1/2 clinical trial. 

Pfizer will start COVID-19 vaccine trial in US next week

No takeover approach, says COVID-19 vaccine developer BioNTe...

Germany’s BioNTech has said it has not received any takeover approaches after it began a high-profile coronavirus vaccine trial with Pfizer in Germany, following press reports over the week

Pfizer, BioNTech aim to start German COVID-19 vaccine trial ...

BMS gets an important win for Opdivo combination in kidney c...